MedPath

Podocon 25

Podocon-25® (25% podophyllin in benzoin tincture)

Approved
Approval ID

a13345b7-c42b-4459-b0ff-03cf91e46b7d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 17, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Podophyllum resin

PRODUCT DETAILS

NDC Product Code63629-8699
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationTOPICAL
Effective DateFebruary 23, 2022
Generic NamePodophyllum resin

INGREDIENTS (3)

PODOPHYLLUM RESINActive
Quantity: 1 mg in 4 mL
Code: 16902YVY2B
Classification: ACTIB
STYRAX BENZOIN RESINInactive
Code: FE663Z8IRO
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Podocon 25 - FDA Drug Approval Details